Skip to main content
. 2011 Jul 27;8:26. doi: 10.1186/1742-6405-8-26

Figure 1.

Figure 1

Frequency of resistance mutations. The percentage of therapies which developed mutation during therapy at the indicated location (top), and which had a preexisting mutation at the indicated location (bottom), by risk group. The patterns are consistent across the different risk groups. Locations are codons associated with significant resistance to one or more RTI compounds, as reported in the 2008 International AIDS Society listing [18].